A study published today in the journal Cell marks the first reported instance of generative AI designing synthetic molecules that can successfully control gene expression in healthy mammalian cells.

Department of Cellular and Molecular Medicine, University of Arizona, Tucson, Arizona 85721-0001, United States Cancer Biology Graduate Interdisciplinary Program, University of Arizona, Tucson, ...

Wadhwani Foundation invests Rs 1,400 crore in AI & synthetic biology research, aiming to convert academic discoveries into startups and jobs. New Delhi, Apr 29 (PTI) The Wadhwani Foundation, which has ...

Wadhwani Foundation partners with ANRF for Rs 1,400 cr research initiative in AI & synthetic biology, aiming to bridge research and product development gap. New Delhi, Apr 29 (PTI) The Wadhwani ...

kit and cells, claims 60-61 are for composition for use in treatment, while claims 62 to 68 are for engineered and/or non-naturally occurring DNA-targeting RNA. This scrutiny clearly reveals that the ...

"We are in a new era where biology is now programmable and accelerated drug development is occurring at the intersection of AI and synthetic biology," said Benjamin Kim, Ph.D., Partner, Playground ...

“We are in a new era where biology is now programmable and accelerated drug development is occurring at the intersection of AI and synthetic biology,” said Benjamin Kim, Ph.D ...

Chen, M.D., Ph.D., a leading physician-scientist and pioneer in the fields of cancer immunotherapy and protein engineering, is founder and CEO of Synthetic Design Lab. A co-author of the renowned ...